The ER, PR, and HER2 states and clinical N stage have been proven to be associated with pCR after NAC in breast cancer (35–38), and the results showed that adding clinical information enables the DLR model to achieve greater predictive efficacy. This evidence concerns the gene PGR and breast carcinoma.